Article Information
History
- December 2, 2020.
Article Versions
- Version 1 (August 14, 2020 - 09:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
REVISION SUMMARY
Major revision according to Reviewer's queries. Additional data included and shift of the manuscript size to a full research paper"
Author Information
- Aymric Kisserli1,2,
- Nathalie Schneider3,
- Sandra Audonnet4,
- Thierry Tabary2,5,
- Antoine Goury6,
- Joel Cousson6,
- Rachid Mahmoudi7,8,
- Firouze Bani-Sadr6,
- Lukshe Kanagaratnam8,9,
- Damien Jolly8,9 and
- Jacques HM Cohen2,*
- 1Oncogeriatric Coordination Unit, Rheims University Hospital, Rheims, France
- 2Nanosciences Research Laboratory LRN EA 4682, University of Rheims Champagne-Ardenne, Rheims, France
- 3Biochemistry, Pharmacology and Toxicology Unit, Rheims University Hospital, Rheims, France
- 4URCACyt, Flow Cytometry Technical Platform, University of Rheims Champagne-Ardenne, Rheims, France
- 5Immunology Laboratory, Rheims University Hospital, Rheims, France
- 6Medical-Surgical ICU, Rheims University Hospital, Rheims, France
- 7Department of Internal Medicine and Geriatrics, Rheims University Hospital, Rheims, France
- 8Aging and Fragility Unit EA 3797, University of Rheims Champagne-Ardenne, Rheims, France
- 9Research Promotion and Support Unit, Rheims University Hospital, Rheims, France
- ↵*Correspondence:
Jacques H. M. Cohen, Laboratoire de Recherche en Nanosciences LRN EA4682 Université de Reims Champagne-Ardenne, 51100 Reims, France ; e-mail : jacques.cohen{at}univreims. fr; tel : +33 611936745.